• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

New “Evolution Engine” Can Mutate Target Genes 100,000 Times Faster Than Normal

August 12, 2025 by Deborah Bloomfield

The evolution of proteins isn’t just something that happens out in the wild. It can happen in the lab, too, and brings with it the possibility of developing new and improved proteins that can be used in all sorts of useful ways. Trouble is, that’s also a massive slog – until now.

The rest of this article is behind a paywall. Please sign in or subscribe to access the full content.

A team from the Department of Chemistry and Skaggs Institute for Chemical Biology at the Scripps Research Institute have developed a so-called “evolution engine”, which can continuously introduce mutations into living bacterial cells at a rate 100,000 times higher than it would naturally acquire them.

“This is like giving evolution a fast-forward button,” said co-senior author Pete Schultz, the President and CEO of Scripps Research, in a statement. “You can now evolve proteins continuously and precisely inside cells without damaging the cell’s genome or requiring labor-intensive steps.”

The “engine” is called T7-ORACLE and works by introducing an artificial DNA replication system into E. coli. Yep, you read that right; not all E. coli gives you an iffy belly – it’s also widely used to produce proteins, as it grows easily and rapidly.

This second, separate replication system doesn’t target E. coli’s main, chromosomal DNA, leaving the host cell unaffected. Instead, it targets small, circular pieces of DNA called plasmids, which are often introduced into bacteria for the purpose of producing large amounts of proteins.

Schematic of the T7-ORACLE system. The genome is maintained by the non-mutagenic host replisome (gray), while an orthogonal T7 replisome (red) maintains only a dedicated plasmid (OR) at 100,000-fold elevated mutation rate.

The T7-ORACLE system.

Image credit: Scripps Research

According to the researchers, it’s a simple system to set up. “The main thing that sets this apart is how easy it is to implement,” said co-senior author Christian Diercks, an assistant professor of chemistry at Scripps Research. “There’s no specialized equipment or expertise required. If you already work with E. coli, you can probably use this system with minimal adjustments.”

The team tested the system out with a gene encoding a protein that gives bacteria antibiotic resistance, and gradually exposed E. coli cells to increasingly high doses of antibiotics. The results were impressively rapid; it took less than a week for a protein to evolve that could handle a dose up to 5,000 times higher than the first.

“This system represents a major advance in continuous evolution,” said Diercks. “Instead of one round of evolution per week, you get a round each time the cell divides – so it really accelerates the process.”

It’s hoped that the T7-ORACLE system could be at its most useful in medicine, helping to speed up the process of finding new and improved therapeutic proteins for all kinds of conditions, including cancers and neurodegenerative diseases.

“What’s exciting is that it’s not limited to one disease or one kind of protein,” Diercks explained. “Because the system is customizable, you can drop in any gene and evolve it toward whatever function you need.”

“[W]e can now evolve virtually any protein, like cancer drug targets and therapeutic enzymes, in days instead of months.”

The study is published in Science.

Deborah Bloomfield
Deborah Bloomfield

Related posts:

  1. Skype alumni head to court in a battle over Starship Technologies and Wire
  2. Fed’s Powell: ‘Frustrating’ that supply chain kinks aren’t getting better
  3. Five Thousand Years Ago, Africa Had A Major Civilization We Forgot
  4. Rubbing A Banana Peel On Your Face Is Not Some Big Skincare Secret – It’s Just Pointless

Source Link: New “Evolution Engine” Can Mutate Target Genes 100,000 Times Faster Than Normal

Filed Under: News

Primary Sidebar

  • NASA’s Voyager Spacecraft Found A 30,000-50,000 Kelvin “Wall” At The Edge Of Our Solar System
  • “Dueling Dinosaurs” Fossil Confirms Nanotyrannus As Own Species, Interstellar Comet 3I/ATLAS Is Back From Behind The Sun, And Much More This Week
  • This Is What Antarctica Would Look Like If All Its Ice Disappeared
  • Bacteria That Can Come Back From The Dead May Have Gone To Space: “They Are Playing Hide And Seek”
  • Earth’s Apex Predators: Meet The Animals That (Almost) Can’t Be Killed
  • What Looks And Smells Like Bird Poop? These Stinky Little Spiders That Don’t Want To Be Snacks
  • In 2020, A Bald Eagle Murder Mystery Led Wildlife Biologists To A Very Unexpected Culprit
  • Jupiter-Bound Mission To Study Interstellar Comet 3I/ATLAS From Deep Space This Weekend
  • The Zombie Worms Are Disappearing And It’s Not A Good Thing
  • Think Before You Toss: Do Not Dump Your Pumpkins In The Woods After Halloween
  • A Nearby Galaxy Has A Dark Secret, But Is It An Oversized Black Hole Or Excess Dark Matter?
  • Newly Spotted Vaquita Babies Offer Glimmer Of Hope For World’s Rarest Marine Mammal
  • Do Bees Really “Explode” When They Mate? Yes, Yes They Do
  • How Do We Brush A Hippo’s Teeth?
  • Searching For Nessie: IFLScience Takes On Cryptozoology
  • Your Halloween Pumpkin Could Be Concealing Toxic Chemicals – And Now We Know Why
  • The Aztec Origins Of The Day Of The Dead (And The Celtic Roots Of Halloween)
  • Large, Bright, And Gold: Get Ready For The Biggest Supermoon Of The Year
  • For Just Two Days A Year, These Male Toads Turn A Jazzy Bright Yellow. Now We Know Why
  • Interstellar Comet 3I/ATLAS Is Back From Behind The Sun – Still Not An Alien Spacecraft, Though
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version